NCT01929434

Brief Summary

Cerebral palsy (CP) is described as a group of permanent disorders affecting motor development and posture, resulting in activity limitation attributed to nonprogressive disturbances of the fetal or infant brain. The prevalence of cerebral palsy has increased among the children with low birth-weight, jaundice, respiratory distress and intrauterine infection and so on. The incidence of cerebral palsy is increasing gradually with increased neonatal survival rate. Although there are many kinds of functional therapy programs especially the rehabilitation treatment for cerebral palsy, their effects are limited. Increasing cerebral palsy patients become a heavy burden to the family and society. Stem cell based therapy, a new prospective therapy for central nervous system disorders, has the potential to repair the damaged brain tissue in patients with cerebral palsy. In this study, 300 patients with cerebral palsy will be divided into three groups and the investigators will use mesenchymal stem cells derived from umbilical cord to treat 100 CP patients of them randomly. We will also follow up the other 100 patients who only receive rehabilitation treatment and another 100 patients who accept neither stem cell therapy nor rehabilitation treatment. On this basis, as the investigators we can compare the efficacy of cell therapy and rehabilitation treatments for cerebral palsy patients. Multiple sources of assessment were used to ascertain and classify all cases of cerebral palsy. Particularly the Gross Motor Function Measure (GMFM) as an important valid and reliable outcome measure, has made it possible to evaluate the severity of movement disability,change over time and the effects of clinical interventions. It also will be the primary outcome measure in follow-up analysis of this study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Oct 2013

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 20, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 28, 2013

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2013

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

December 27, 2017

Status Verified

July 1, 2015

Enrollment Period

2.2 years

First QC Date

August 20, 2013

Last Update Submit

December 23, 2017

Conditions

Keywords

cerebral palsycell transplantationrehabilitation

Outcome Measures

Primary Outcomes (1)

  • Gross Motor Function Measure Score

    Gross Motor Function Measure-88 and Gross Motor Function Measure-66

    Change from baseline at 12 monthes after enrollment or transplantation

Secondary Outcomes (1)

  • Routine Blood Test and Biochemical Test

    Change from baseline at 12 monthes after enrollment or transplantation

Other Outcomes (1)

  • Magnetic resonance imaging (MRI)

    Change from baseline at 12 monthes after enrollment or transplantation

Study Arms (3)

rehabilitation

ACTIVE COMPARATOR

Patients in the group accept rehabilitation for three weeks in hospital and other eleven months in their home under the guidance of physical therapist.

Other: rehabilitation

control

NO INTERVENTION

Patients receive no professional treatment in hospital or rehabilitation centre.

stem cell injection

EXPERIMENTAL

Patients in the group accept cell therapy including four times stem cells transplant via intrathecal injection.

Biological: stem cell injection

Interventions

Patients only receive rehabilitation of physical therapy and occupational therapy.

Also known as: phsical exercise rehabilitation
rehabilitation

Mesenchymal stem cells derived from umbilical cord are transplanted directly into subarachnoid by Lumbar puncture.

stem cell injection

Eligibility Criteria

Age1 Year - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients with diagnosis of cerebral palsy.
  • Patients' curator must be able to give voluntary consent.

You may not qualify if:

  • Intracranial infection.
  • Severe respiratory and circulatory system diseases.
  • Hematologic malignancies.
  • Positive serological tests such as AIDS, hepatitis B virus, hepatitis C virus and syphilis (antigen or antibody).
  • Tumors.
  • Genetic and metabolic diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

General Hospital of Chinese People's Armed Police Forces

Beijing, Beijing Municipality, 100050, China

Location

Related Publications (6)

  • Pharoah PO, Platt MJ, Cooke T. The changing epidemiology of cerebral palsy. Arch Dis Child Fetal Neonatal Ed. 1996 Nov;75(3):F169-73. doi: 10.1136/fn.75.3.f169.

    PMID: 8976681BACKGROUND
  • Richards CL, Malouin F. Cerebral palsy: definition, assessment and rehabilitation. Handb Clin Neurol. 2013;111:183-95. doi: 10.1016/B978-0-444-52891-9.00018-X.

    PMID: 23622163BACKGROUND
  • Himmelmann K. Epidemiology of cerebral palsy. Handb Clin Neurol. 2013;111:163-7. doi: 10.1016/B978-0-444-52891-9.00015-4. No abstract available.

    PMID: 23622160BACKGROUND
  • Reddihough DS, Collins KJ. The epidemiology and causes of cerebral palsy. Aust J Physiother. 2003;49(1):7-12. doi: 10.1016/s0004-9514(14)60183-5.

    PMID: 12600249BACKGROUND
  • Rethlefsen SA, Ryan DD, Kay RM. Classification systems in cerebral palsy. Orthop Clin North Am. 2010 Oct;41(4):457-67. doi: 10.1016/j.ocl.2010.06.005.

    PMID: 20868878BACKGROUND
  • Lubis MU, Tjipta GD, Marbun MD, Saing B. Cerebral palsy. Paediatr Indones. 1990 Mar-Apr;30(3-4):65-70.

    PMID: 2075008BACKGROUND

MeSH Terms

Conditions

Cerebral Palsy

Interventions

Rehabilitation

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Yihua An, Doctor

    the General Hospital of Chinese People's Armed Police Forces

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2013

First Posted

August 28, 2013

Study Start

October 1, 2013

Primary Completion

December 1, 2015

Study Completion

December 1, 2016

Last Updated

December 27, 2017

Record last verified: 2015-07

Locations